Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Medication

Medication Recalls

Browse drug and medication recalls including prescription drugs, OTC medications, and supplements. Stay informed about pharmaceutical safety alerts.

Get alerts for medication RSS feed

Showing 421–440 of 1639 recalls

Filter by date, severity, state →

Pravastatin Sodium Tablets (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Solifenacin Succinate Tablets (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Prochlorperazine Maleate Tablets (Glenmark) – CGMP Issues (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Voriconazole Tablets 50mg (Glenmark) – CGMP Issues (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Acetaminophen and Ibuprofen Tablets (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Ranolazine Extended-Release 1000mg (Glenmark) – CGMP Issues (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Indomethacin Extended-Release Capsules 75mg (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Frovatriptan Succinate Tablets 2.5mg (Glenmark) – CGMP Issues (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Teriflunomide Tablets 14mg (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Solifenacin Succinate Tablets 10mg (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Pravastatin Sodium Tablets 20mg (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Nitroglycerin Sublingual Tablets 0.3mg (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Pravastatin Sodium Tablets (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Class IIModerate

FDAMar 13, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

ChlorproMAZINE Tablets 100mg (Glenmark) – CGMP Deviations (2025)

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Class IIModerate

FDAMar 11, 2025Nationwide• Glenmark Pharmaceuticals Inc., USA

Ciprofloxacin Ophthalmic Solution (FDC) – Defective Container (2025)

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Class IIModerate

FDAMar 11, 2025Nationwide• FDC Limited

Cinacalcet Hydrochloride Tablets (Slate Run Pharmaceuticals) – Nitrosamine Impurity (2025)

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Class IIModerate

FDAMar 7, 2025Nationwide• Slate Run Pharmaceuticals

Levothyroxine Sodium Tablets (Mylan) – Super-Potent Drug (2025)

Super-Potent Drug: Out of specification potency results were obtained.

Class IIModerate

FDAMar 7, 2025Nationwide• Mylan Institutional, Inc.

Duloxetine D/R (Direct Rx) – Nitrosamine Impurity (2025)

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Class IIModerate

FDAMar 7, 2025Nationwide• Direct Rx

Cinacalcet Hydrochloride Tablets (Slate Run Pharmaceuticals) – Nitrosamine Impurity (2025)

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Class IIModerate

FDAMar 7, 2025Nationwide• Slate Run Pharmaceuticals

Sofosbuvir and Velpatasvir (ASEGUA) – Defective Container (2025)

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Class IIModerate

FDAMar 7, 2025Nationwide• ASEGUA THERAPEUTICS LLC

1...20 212223 24...82

Page 22 of 82Next

Browse Other Categories

Food Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other